全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

外泌体在医学领域的应用
Application of Exosomes in Medical Field

DOI: 10.12677/ACM.2023.132185, PP. 1341-1345

Keywords: 外泌体,医学应用
Exosomes
, Medical Application

Full-Text   Cite this paper   Add to My Lib

Abstract:

外泌体是一种存在于细胞外囊泡中的物质,且其含有多种成分,如蛋白质、脂质和核酸等,是一种双磷脂膜囊泡。外泌体几乎由人体所有的细胞分泌,在各种体液中都能检测到,在细胞间的连接中占有举足轻重的地位。外泌体的作用表现为细胞间的连接,免疫调节,信号传导细胞的再生和分化,形成血管,凋亡,呈递抗原等。并且外泌体所含成分具有明显的特异性,利用此特性,如癌症及病毒感染、多囊卵巢症候群等,其可视为疾病的生物标记,作为诊断之用。外泌体也曾尝试作为载体,将药物输送出去,如一些抗肿瘤药的应用。外泌体在疾病中行使的功能使它在临床上的应用具有很大的优越性。本文主要从外泌体的发现、及其在相关疾病(皮肤创面修复,阿尔茨海默病,肿瘤治疗)的研究进展这2个方面加以阐述。
Exosomes are substances existing in extracellular vesicles, and they contain a variety of compo-nents, such as protein, lipid and nucleic acid. They are double phospholipid membrane vesicles. The exosomes are secreted by almost all cells of the human body, can be detected in various body fluids, and play an important role in the connection between cells. The functions of exosomes include cell to cell connection, immune regulation, regeneration and differentiation of signal transduction cells, formation of blood vessels, apoptosis, antigen presentation, etc. In addition, the components con-tained in the exosomes have obvious specificity. With this characteristic, such as cancer, virus infec-tion, polycystic ovary syndrome, etc., they can be regarded as biomarkers of diseases for diagnosis. The exosomes have also tried to be used as carriers to deliver drugs, such as the application of some anti-tumor drugs. The function of exocrine body in disease makes it have great advantages in clini-cal application. This article mainly discusses the discovery of exocrine body and its research pro-gress in related diseases (skin wound repair, Alzheimer’s disease, tumor treatment).

References

[1]  Kourembanas, S. (2015) Exosomes Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy. Annual Review of Physiology, 77, 13-27.
https://doi.org/10.1146/annurev-physiol-021014-071641
[2]  Pan, B.T. and Johnstone, R.M. (1983) Fate of the Transferrin Receptor during Maturation of Sheep Reticulocytes in Vitro: Selective Externalization of the Receptor. Cell, 33, 967-978.
https://doi.org/10.1016/0092-8674(83)90040-5
[3]  Johnstone, R.M., Adam, M., Hammond, J.R., et al. (1987) Vesicle Formation during Reticulocyte Maturation. Association of Plas-ma Membrane Activities with Released Vesicles (Exosomes). Journal of Biological Chemistry, 262, 9412-9420.
https://doi.org/10.1016/S0021-9258(18)48095-7
[4]  Raposo, G. and Stoorvogel, W. (2013) Extracellular Vesicles: Exosomes, Microvesicles, and Friends. Journal of Cell Biology, 200, 373-383.
https://doi.org/10.1083/jcb.201211138
[5]  Tkach, M. and Thery, C. (2016) Communication by Extracellular Vesi-cles: Where We Are and Where We Need to Go. Cell, 164, 1226-1232.
https://doi.org/10.1016/j.cell.2016.01.043
[6]  Lipsky, P.E. (2001) Systemic Lupus Erythematosus: An Autoim-mune Disease of B Cell Hyperactivity. Nature Immunology, 2, 764-766.
https://doi.org/10.1038/ni0901-764
[7]  Nosbaum, A., Prevel, N., Truong, H.-A., et al. (2016) Regulatory T Cells Facilitate Cutaneous Wound Healing. The Journal of Immunology, 196, 2010-2014.
https://doi.org/10.4049/jimmunol.1502139
[8]  Monguió-Tortajada, M., Roura, S., Gálvez-Montón, C., et al. (2017) Nanosized UCMSC-Derived Extracellular Vesicles but Not Conditioned Medium Exclusively Inhibit the Inflam-matory Response of Stimulated T Cells: Implications for Nanomedicine. Theranostics, 7, 270-284.
https://doi.org/10.7150/thno.16154
[9]  Hatanaka, E., Monteagudo, P.T., Marrocos, M.S.M., et al. (2006) Neu-trophils and Monocytes as Potentially Important Sources of Proinflammatory Cytokines in Diabetes. Clinical & Experi-mental Immunology, 146, 443-447.
https://doi.org/10.1111/j.1365-2249.2006.03229.x
[10]  Yang, J., Liu, X.X., Fan, H., et al. (2015) Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Co-lon Inflammation, Oxidative Stress and Apoptosis. PLOS ONE, 10, e0140551.
https://doi.org/10.1371/journal.pone.0140551
[11]  Li, X., Liu, L., Yang, J., et al. (2016) Exosome Derived from Human Umbilical Cord Mesenchymal Stem Cell Mediates MiR-181c Attenuating Burn-Induced Excessive Inflammation. EBioMedicine, 8, 72-82.
https://doi.org/10.1016/j.ebiom.2016.04.030
[12]  Zhang, J., Guan, J., Niu, X., et al. (2015) Exosomes Released from Human Induced Pluripotent Stem Cells-Derived MSCs Facilitate Cutaneous Wound Healing by Promoting Colla-gen Synthesis and Angiogenesis. Journal of Translational Medicine, 13, 49.
https://doi.org/10.1186/s12967-015-0417-0
[13]  Zhang, B., Wu, X., Zhang, X., et al. (2015) Human Umbilical Cord Mesenchymal Stem Cell Exosomes Enhance Angiogenesis through the Wnt4/β-Catenin Pathway. Stem Cells Translational Medicine, 4, 513-522.
https://doi.org/10.5966/sctm.2014-0267
[14]  Guo, S.C., Tao, S.C., Yin, W.J., et al. (2017) Exosomes Derived from Platelet-Rich Plasma Promote the Re-Epithelization of Chronic Cutaneous Wounds via Activation of YAP in a Dia-betic Rat Model. Theranostics, 7, 81-96.
https://doi.org/10.7150/thno.16803
[15]  Jia, L., Qiu, Q., Zhang, H., et al. (2019) Concordance between the Assessment of Abeta42, T-Tay, and P-T181-Tauinperipheral Blood Neuronal-Derived Exosomes and Cerebrospinal Fluid. Alzheimer’s & Dementia, 15, 1071.
https://doi.org/10.1016/j.jalz.2019.05.002
[16]  Li, Y., Meng, S., Di, W., et al. (2022) Amyloid-beta Protein and MicroRNA-384 in NCAM-Labeled Exosomes from Peripheral Blood Are Potential Diagnostic Markers for Alzheimer’s Disease. CNS Neuroscience & Therapeutics, 28, 1093.
https://doi.org/10.1111/cns.13846
[17]  Goetzl, E.J., Abner, E.L., Jicha, G.A., et al. (2018) Declining Levels of Functional Lyspecialized Synaptic Proteins in Plasma Neuronal Exo-somes with Progression of Alzheimer’s Disease. The FASEB Journal, 32, 888.
https://doi.org/10.1096/fj.201700731R
[18]  Soaresmartins, T., Trindade, D., Vaz, M., et al. (2021) Diagnostic and Therapeutic Potential of Exosomes in Alzheimer’s Disease. Journal of Neurochemistry, 156, 162.
https://doi.org/10.1111/jnc.15112
[19]  Alvares-erviti, L., Seow, Y., Yin, H., et al. (2011) Delivery of siRNA to the Mouse Brain by Systemic Injection of Targeted Exosomes. Nature Biotechnology, 29, 341.
https://doi.org/10.1038/nbt.1807
[20]  Chen, W., Huang, Y., Han, J., et al. (2016) Immunomodulatory Effects of Mesenchymal Stromal Cells-Derived Exosome. Immunologic Research, 64, 831.
https://doi.org/10.1007/s12026-016-8798-6
[21]  Kzhyshkowska, J., Bizzarri, M., Apte, R., et al. (2017) Editorial: Targeting of Cancer Cells and Tumor Microenvironment: Perspectives for Personalized Therapy. Current Pharmaceuti-cal Design, 23, 4703-4704.
https://doi.org/10.2174/138161282332171221165319
[22]  Escudier, B., Dorval, T., Chaput, N., et al. (2005) Vac-cination of Metastatic Melanoma Patients with Autologous Dendritic Cell (DC) Derived-Exosomes: Results of the First Phase I Clinical Trial. Journal of Translational Medicine, 3, Article No. 10.
https://doi.org/10.1186/1479-5876-3-10
[23]  Sun, W., Luo, J.D., Jiang, H. and Duan, D.D. (2018) Tumor Exo-somes: A Double-Edged Sword in Cancer Therapy. Acta Pharmacologica Sinica, 39, 534-541.
https://doi.org/10.1038/aps.2018.17

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133